160 related articles for article (PubMed ID: 15205083)
1. Safety profiles of Fe2+ and Fe3+ oral preparations in the treatment of iron deficiency anemia in children.
Kavakli K; Yilmaz D; Cetinkaya B; Balkan C; Sözmen EY; Sağin FG
Pediatr Hematol Oncol; 2004; 21(5):403-10. PubMed ID: 15205083
[TBL] [Abstract][Full Text] [Related]
2. Ferrous sulfate (Fe2+) had a faster effect than did ferric polymaltose (Fe3+) on increased oxidant status in children with iron-deficiency anemia.
Aycicek A; Koc A; Oymak Y; Selek S; Kaya C; Guzel B
J Pediatr Hematol Oncol; 2014 Jan; 36(1):57-61. PubMed ID: 23743961
[TBL] [Abstract][Full Text] [Related]
3. Malondialdehyde, antioxidant enzymes, and renal tubular functions in children with iron deficiency or iron-deficiency anemia.
Altun D; Kurekci AE; Gursel O; Hacıhamdioglu DO; Kurt I; Aydın A; Ozcan O
Biol Trace Elem Res; 2014 Oct; 161(1):48-56. PubMed ID: 25099508
[TBL] [Abstract][Full Text] [Related]
4. Iron deficiency anemia and levels of oxidative stress induced by treatment modality.
Akarsu S; Demir H; Selek S; Oguzoncul F
Pediatr Int; 2013 Jun; 55(3):289-95. PubMed ID: 23316876
[TBL] [Abstract][Full Text] [Related]
5. Letter to the editor: treatment of iron deficiency anemia.
Ozsoylu S
Pediatr Hematol Oncol; 2005; 22(7):645-6; author reply 647-8. PubMed ID: 16166057
[No Abstract] [Full Text] [Related]
6. Comparison of Different Iron Preparations in the Prophylaxis of Iron-deficiency Anemia.
Aydin A; Gur E; Erener-Ercan T; Can G; Arvas A
J Pediatr Hematol Oncol; 2017 Oct; 39(7):495-499. PubMed ID: 28872486
[TBL] [Abstract][Full Text] [Related]
7. Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children.
Bopche AV; Dwivedi R; Mishra R; Patel GS
Indian Pediatr; 2009 Oct; 46(10):883-5. PubMed ID: 19430060
[TBL] [Abstract][Full Text] [Related]
8. Effect of iron supplementation on oxidative stress and antioxidant status in iron-deficiency anemia.
Kurtoglu E; Ugur A; Baltaci AK; Undar L
Biol Trace Elem Res; 2003; 96(1-3):117-23. PubMed ID: 14716090
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ferrous sulfate, polymaltose complex and iron-zinc in iron deficiency anemia.
Ozsurekci Y; Unal S; Cetin M; Gumruk F
Minerva Pediatr; 2019 Oct; 71(5):449-454. PubMed ID: 26200522
[TBL] [Abstract][Full Text] [Related]
10. Monitoring oral iron therapy in children with iron deficiency anemia: an observational, prospective, multicenter study of AIEOP patients (Associazione Italiana Emato-Oncologia Pediatrica).
Russo G; Guardabasso V; Romano F; Corti P; Samperi P; Condorelli A; Sainati L; Maruzzi M; Facchini E; Fasoli S; Giona F; Caselli D; Pizzato C; Marinoni M; Boscarol G; Bertoni E; Casciana ML; Tucci F; Capolsini I; Notarangelo LD; Giordano P; Ramenghi U; Colombatti R
Ann Hematol; 2020 Mar; 99(3):413-420. PubMed ID: 31965272
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness and tolerability of oral liquid ferrous gluconate in iron-deficiency anemia in pregnancy and in the immediate post-partum period: comparison with other liquid or solid formulations containing bivalent or trivalent iron].
Casparis D; Del Carlo P; Branconi F; Grossi A; Merante D; Gafforio L
Minerva Ginecol; 1996 Nov; 48(11):511-8. PubMed ID: 9005381
[TBL] [Abstract][Full Text] [Related]
12. Effects of a Tripeptide Iron on Iron-Deficiency Anemia in Rats.
Xiao C; Lei X; Wang Q; Du Z; Jiang L; Chen S; Zhang M; Zhang H; Ren F
Biol Trace Elem Res; 2016 Feb; 169(2):211-7. PubMed ID: 26109335
[TBL] [Abstract][Full Text] [Related]
13. Lipid peroxidation and antioxidant status in beta-thalassemia.
Meral A; Tuncel P; Sürmen-Gür E; Ozbek R; Oztürk E; Günay U
Pediatr Hematol Oncol; 2000 Dec; 17(8):687-93. PubMed ID: 11127401
[TBL] [Abstract][Full Text] [Related]
14. Superoxide dismutase and glutathione peroxidase in erythrocytes of patients with iron deficiency anemia: effects of different treatment modalities.
Isler M; Delibas N; Guclu M; Gultekin F; Sutcu R; Bahceci M; Kosar A
Croat Med J; 2002 Feb; 43(1):16-9. PubMed ID: 11828552
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.
Prats M; Font R; García C; Muñoz-Cortés M; Cabré C; Jariod M; Romeu M; Giralt M; Martinez-Vea A
Clin Nephrol; 2014 Jun; 81(6):419-26. PubMed ID: 24691014
[TBL] [Abstract][Full Text] [Related]
16. Effects of iron(II) salts and iron(III) complexes on trace element status in children with iron-deficiency anemia.
Sözmen EY; Kavakli K; Cetinkaya B; Akçay YD; Yilmaz D; Aydinok Y
Biol Trace Elem Res; 2003 Jul; 94(1):79-86. PubMed ID: 12907830
[TBL] [Abstract][Full Text] [Related]
17. Effect of squid ink melanin-Fe on iron deficiency anemia remission.
Lei M; Xue CH; Wang YM; Li ZJ; Xue Y; Wang JF
J Food Sci; 2008 Oct; 73(8):H207-11. PubMed ID: 19019117
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of intravenous and oral iron in chronic kidney disease.
Agarwal R; Kusek JW; Pappas MK
Kidney Int; 2015 Oct; 88(4):905-14. PubMed ID: 26083656
[TBL] [Abstract][Full Text] [Related]
19. [Comparative evaluation of efficacy and tolerance of iron polymaltose complex and ferrous sulphate for treatment of iron deficiency anemia in infants].
Amaral D; Galimberti G; Cuesta S; Pinto J; Ferrario C; Graciela E
Rev Fac Cien Med Univ Nac Cordoba; 2012; 69(2):97-101. PubMed ID: 23286539
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Therapeutic Effects and Side Effects of Oral Iron Supplements in Iron Deficiency Anemia.
Wu TW; Tsai FP
Drug Res (Stuttg); 2016 May; 66(5):257-61. PubMed ID: 26697889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
